Annual EBITDA
$1.63B$170.88M+11.68%
Summary
- Current Value
- As of today, STE annual EBITDA is $1.63B, up +11.68% on
- Historical Performance
- STE annual EBITDA is up +19.76% over the past 3 years, up +97.49% over the past 5 years
- All-Time High Comparison
- STE annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- STE annual EBITDA is +19.76% above its 3-year low of $1.36B reached on an earlier date
- Sector Comparison
- STE annual EBITDA is higher than 94.87% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.63B | +11.7% | +19.8% | +97.5% | +1076.9% | |
| Quarterly EBITDA | $445.20M | +14.0% | +23.7% | +77.3% | +556.3% | |
| TTM EBITDA | $1.73B | +11.6% | +23.1% | +86.0% | +587.9% | |
| Price | $254.76 | +0.0% | +27.2% | +9.1% | +791.4% | |
| PE Ratio | 30.23 | -16.6% | -16.6% | -63.6% | +110.5% | |
| Annual Revenue | $5.94B | +8.7% | +30.9% | +91.0% | +391.6% | |
| Annual EPS | $7.93 | +24.9% | +642.3% | +71.3% | +832.5% | |
| $1.11B | +12.1% | +36.3% | +81.9% | +1210.1% | ||
| Annual Net Income | $785.10M | +28.4% | +41.2% | +97.8% | +1431.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.63B | at high | |
| 5Y | $1.63B | at high | |
| All | $1.63B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.36B | N/A | +19.8% |
| 5Y | $827.18M | N/A | +97.5% |
| All | $212.10K | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of STE?
- As of today, STE annual EBITDA is $1.63B
- What is 1-year change in STE annual EBITDA?
- STE annual EBITDA is up +11.68% year-over-year
- What is 3-year change in STE annual EBITDA?
- STE annual EBITDA is up +19.76% over the past 3 years
- How far is STE annual EBITDA from its all-time high?
- STE annual EBITDA is currently at its all-time high
- How does STE annual EBITDA rank versus sector peers?
- STE annual EBITDA is higher than 94.87% of companies in Healthcare sector
- When is STE next annual earnings release?
- As of today, the next annual earnings release for STE has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$445.20M$37.10M+9.09%
Summary
- Current Value
- As of today, STE quarterly EBITDA is $445.20M, up +9.09% on
- Historical Performance
- STE quarterly EBITDA is up +13.98% year-over-year, up +23.71% over the past 3 years
- All-Time High Comparison
- STE quarterly EBITDA is currently -6.73% below its historical high of $477.30M set on
- 3-Year Low Comparison
- STE quarterly EBITDA is +30.73% above its 3-year low of $340.55M reached on
- Sector Comparison
- STE quarterly EBITDA is higher than 93.94% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $445.20M | +9.1% | +14.0% | +23.7% | +77.3% | |
| Annual EBITDA | $1.63B | – | +11.7% | +19.8% | +97.5% | |
| TTM EBITDA | $1.73B | +3.3% | +11.6% | +23.1% | +86.0% | |
| Price | $254.76 | +7.5% | +0.0% | +27.2% | +9.1% | |
| PE Ratio | 30.23 | +4.4% | -16.6% | -16.6% | -63.6% | |
| Quarterly Revenue | $1.59B | +6.4% | +8.8% | +28.3% | +32.7% | |
| Quarterly EPS | $2.19 | +7.1% | +12.7% | +88.7% | +215.8% | |
| $313.30M | +10.2% | +16.5% | +50.9% | +135.4% | ||
| Quarterly Net Income | $214.10M | +6.5% | +11.2% | +77.2% | +207.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $477.30M | -6.7% | |
| 3Y | $477.30M | -6.7% | |
| 5Y | $477.30M | -6.7% | |
| All | $477.30M | -6.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $390.60M | N/A | +14.0% |
| 3Y | $340.55M | +30.7% | |
| 5Y | $251.13M | N/A | +77.3% |
| All | -$49.62M | +997.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of STE?
- As of today, STE quarterly EBITDA is $445.20M
- What is STE quarterly EBITDA most recent change?
- STE quarterly EBITDA was up +9.09% on September 30, 2026
- What is 1-year change in STE quarterly EBITDA?
- STE quarterly EBITDA is up +13.98% year-over-year
- How far is STE quarterly EBITDA from its all-time high?
- STE quarterly EBITDA is currently -6.73% below its historical high of $477.30M set on March 31, 2026
- How does STE quarterly EBITDA rank versus sector peers?
- STE quarterly EBITDA is higher than 93.94% of companies in Healthcare sector
- When is STE next earnings release?
- The next earnings release for STE is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$1.73B$54.60M+3.26%
Summary
- Current Value
- As of today, STE TTM EBITDA is $1.73B, up +3.26% on
- Historical Performance
- STE TTM EBITDA is up +11.59% year-over-year, up +23.12% over the past 3 years
- All-Time High Comparison
- STE TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- STE TTM EBITDA is +23.12% above its 3-year low of $1.40B reached on an earlier date
- Sector Comparison
- STE TTM EBITDA is higher than 94.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.73B | +3.3% | +11.6% | +23.1% | +86.0% | |
| Annual EBITDA | $1.63B | – | +11.7% | +19.8% | +97.5% | |
| Quarterly EBITDA | $445.20M | +9.1% | +14.0% | +23.7% | +77.3% | |
| Price | $254.76 | +7.5% | +0.0% | +27.2% | +9.1% | |
| PE Ratio | 30.23 | +4.4% | -16.6% | -16.6% | -63.6% | |
| TTM Revenue | $6.17B | +2.1% | +8.1% | +25.4% | +60.2% | |
| TTM EPS | $8.43 | +3.0% | +20.0% | +52.6% | +199.4% | |
| $1.23B | +3.8% | +15.8% | +47.2% | +100.7% | ||
| TTM Net Income | $829.90M | +2.7% | +20.1% | +49.0% | +231.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.73B | at high | |
| 3Y | $1.73B | at high | |
| 5Y | $1.73B | at high | |
| All | $1.73B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.55B | N/A | +11.6% |
| 3Y | $1.40B | N/A | +23.1% |
| 5Y | $929.67M | N/A | +86.0% |
| All | -$6.70M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of STE?
- As of today, STE TTM EBITDA is $1.73B
- What is STE TTM EBITDA most recent change?
- STE TTM EBITDA was up +3.26% on September 30, 2026
- What is 1-year change in STE TTM EBITDA?
- STE TTM EBITDA is up +11.59% year-over-year
- How far is STE TTM EBITDA from its all-time high?
- STE TTM EBITDA is currently at its all-time high
- How does STE TTM EBITDA rank versus sector peers?
- STE TTM EBITDA is higher than 94.51% of companies in Healthcare sector
- When is STE next earnings release?
- The next earnings release for STE is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- STE Official Website www.steris.com
- STE Profile on Yahoo Finance finance.yahoo.com/quote/STE
- STE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ste
